SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-041753
Filing Date
2021-02-12
Accepted
2021-02-12 16:46:59
Documents
19
Period of Report
2021-02-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d135012d8k.htm   iXBRL 8-K 32142
2 EX-1.1 d135012dex11.htm EX-1.1 213215
3 EX-5.1 d135012dex51.htm EX-5.1 9874
4 EX-99.1 d135012dex991.htm EX-99.1 7146
5 EX-99.2 d135012dex992.htm EX-99.2 7361
9 GRAPHIC g135012g0212131621921.jpg GRAPHIC 2534
10 GRAPHIC g135012g0212131645898.jpg GRAPHIC 3719
11 GRAPHIC g135012g0212131702700.jpg GRAPHIC 3719
  Complete submission text file 0001193125-21-041753.txt   474816

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tvtx-20210211.xsd EX-101.SCH 3093
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tvtx-20210211_lab.xml EX-101.LAB 17373
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tvtx-20210211_pre.xml EX-101.PRE 10968
12 EXTRACTED XBRL INSTANCE DOCUMENT d135012d8k_htm.xml XML 3304
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 21628724
SIC: 2834 Pharmaceutical Preparations